Memorandum of understanding on working arrangements

Similar documents
European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

The European Medicines Agency Code of Good Administrative Behaviour

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

Decision of the Executive Director

Mandate, objectives and rules of procedure for the Inter- Committee Scientific Advisory Group (SAG) for Oncology

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

MEMORANDUM OF UNDERSTANDING BETWEEN THE EUROPEAN CHEMICALS AGENCY AND THE EUROPEAN FOOD SAFETY AUTHORITY COVER NOTE

Mandate, objectives and rules of procedure

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

European Medicines Agency decision

Mandate, objectives and rules of procedure

European Medicines Agency decision

The PCWP will now collaborate with the Agency in the revision, implementation and monitoring of the framework of interaction.

European Medicines Agency decision

European Medicines Agency decision

RULES OF PROCEDURE. The Scientific Committees on. Consumer Safety (SCCS) Health and Environmental Risks (SCHER)

European Medicines Agency decision

B REGULATION (EC) No 1831/2003 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 22 September 2003 on additives for use in animal nutrition

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL FOR AGRICULTURE AND RURAL DEVELOPMENT

Title: Handling of Paediatric Art. 45 work sharing procedures by the CMDh Secretariat

Procedural advice to applicants/marketing authorisation holders on re-examination of CVMP opinions

(Acts whose publication is obligatory) of 23 February 2005

EUROPEAN MEDICINES AGENCY DECISION. of 27 January 2009

European Medicines Agency decision

Official Journal of the European Union

(Text with EEA relevance) (2010/C 122 E/03)

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

(Legislative acts) REGULATIONS

European Medicines Agency decision

REGULATION (EU) No 649/2012 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 4 July 2012 concerning the export and import of hazardous chemicals

P7_TA-PROV(2014)0125 Biocidal products ***I

EUROPEAN MEDICINES AGENCY DECISION. of 24 June 2008

11261/2/09 REV 2 TT/NC/ks DG I

13346/15 JDC/psc 1 DPG

European Medicines Agency decision

EUROPEAN MEDICINES AGENCY DECISION. of 30 October 2009

DGB 3B EUROPEAN UNION. Brussels, 5 November 2015 (OR. en) 2013/0435 (COD) PE-CONS 38/15 DENLEG 90 AGRI 362 CODEC 956

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a COUNCIL DECISION

COMMISSION DECISION. of on establishing Scientific Committees in the field of public health, consumer safety and the environment

European Medicines Agency decision

Food Act 1. Passed RT I 1999, 30, 415 Entered into force in accordance with 66.

European Medicines Agency decision

European Medicines Agency Inspections

Coordination group for Mutual recognition and Decentralised procedures (veterinary) RULES OF PROCEDURE

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

EFSA s policy on independence. How the European Food Safety Authority assures the impartiality of professionals contributing to its operations.

EUROPEAN MEDICINES AGENCY DECISION. of 30 October 2009

Rules of Procedures of the EFTA Surveillance Authority *

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a COUNCIL DECISION

EUROPEAN MEDICINES AGENCY DECISION. of 29 February 2008

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a COUNCIL DECISION

Official Journal of the European Union L 334/7

European Medicines Agency decision

EUROPEAN MEDICINES AGENCY DECISION. of 23 December 2009

European Medicines Agency decision

(17) It is necessary to update the legal references in Chapters 3, 12, 14, 16, 18 and 19 of Annex 1 to the Agreement; (18) Article 10(5) of the

Output of the European Medicines Agency policy on access to documents related to corporate documents

Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

European Medicines Agency decision

(Legislative acts) REGULATIONS REGULATION (EU) 2017/625 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 15 March 2017

Food Act 1. Passed RT I 1999, 30, 415 Entered into force in accordance with 66.

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

EUROPEAN MEDICINES AGENCY DECISION. of 15 July 2009

EUROPEAN MEDICINES AGENCY DECISION. of 15 June 2009

EU-Mexico Free Trade Agreement EU TEXTUAL PROPOSAL. Chapter on Sanitary and Phytosanitary Measures

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

1 von :12

EUROPEAN MEDICINES AGENCY DECISION. of 8 March 2010

Official Journal of the European Union. (Acts whose publication is obligatory)

DECISION OF THE EEA JOINT COMMITTEE No 92/2005. of 8 July amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement

Japan-EU EPA (SPS) (Non-Paper) Article 1: Objectives

GAS COORDINATION GROUP RULES OF PROCEDURE

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a COUNCIL REGULATION. on marketing standards for eggs. (presented by the Commission)

COMMISSION OF THE EUROPEAN COMMUNITIES. Adaptation to the regulatory procedure with scrutiny Part One. Proposal for a

European Medicines Agency decision

Opinion 3/2019 concerning the Questions and Answers on the interplay between the Clinical Trials Regulation (CTR) and the General Data Protection

Official Journal of the European Union L 186/1. (Acts whose publication is obligatory)

European Medicines Agency decision

Council of the European Union Brussels, 24 October 2017 (OR. en)

European Medicines Agency decision

Organic Farming Act. Passed RT I 2006, 43, 327 Entry into force

Transcription:

26 January 2012 Memorandum of understanding on working arrangements between the European Medicines Agency and the European Food Safety Authority THE EUROPEAN MEDICINES AGENCY AND THE EUROPEAN FOOD SAFETY AUTHORITY, Having regard to the respective mandates under Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency 1 and under Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing a European Food Safety Authority and laying down procedures in matters of food safety 2, and in particular Article 23 thereof, Recalling the cooperation of the European Medicines Agency (hereinafter referred to as 'EMA') with other European Union bodies for early identification and management of potential conflicts over scientific opinions, and in particular the reference to the remit of EFSA as contained in Article 85 of Regulation (EC) No 726/2004, Recalling the remit of the European Food Safety Authority (hereinafter referred to as 'EFSA'), and in particular its duty to identify and handle at early stage potential contentious scientific issues in accordance with Article 31 of Regulation (EC) No 178/2002 and the reference to the remit of EMA as contained in Article 63 of Regulation (EC) No 178/2002, Recalling that in relation to food-producing animals and to foodstuff of animal origin it is, as a result of scientific and technical progress, possible to detect the presence of residues of veterinary medicinal products in foodstuffs at ever lower levels and that consequently Regulation (EC) No 470/2009 of the European Parliament and of the Council laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of 1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 31, 1.2.2002, p. 1. European Medicines Agency 7 Westferry Circus Canary Wharf London E14 4HB UK Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8416 E-mail info@ema.europa.eu Website www.ema.europa.eu European Food Safety Authority Via Carlo Magno 1A 43126 Parma ITALY Telephone +39 (0)521 036111 Facsimile +39 (0)521 036110 Website www.efsa.europa.eu European Medicines Agency and European Food Safety Authority, 2012. Reproduction is authorised provided the source is acknowledged.

the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council 3, and in particular Articles 1 and 2, Article 4(2) and Article 18 of Regulation (EC) No 470/2009 take account of related remits and mandates of EMA and EFSA, Recalling that it is nevertheless important to avoid confusion between the missions of EMA and EFSA, Taking note with satisfaction of the progress achieved so far in the exchange of information and expertise, and considering that it is within their common interest to enhance further their cooperation, while avoiding duplication of efforts and overlaps in their respective activities, and ensuring the best use of available resources, HAVE AGREED AS FOLLOWS: 1. Purpose of the Memorandum of Understanding: Enhanced cooperation and avoiding of duplication EMA and EFSA as Parties of the present Memorandum of Understanding commit to fostering cooperation between the two agencies in the field of activities identified below based on the principles of appropriateness, common interest, reciprocity and complementarity. The implementation of this Memorandum of Understanding aims in particular at avoiding duplication, at further developing the scientific excellence and the other core values of the two agencies involved, at optimising of the use of risk assessment capacity across the European Union, at developing and harmonising methodologies and approaches to assessing risks associated with the remit of the agencies involved, and at strengthening the evidence basis for risk assessment and risk monitoring. 2. Areas of cooperation Cooperation between the two agencies encompasses in particular the following areas, in accordance with the respective mandates of the agencies: exchange of information and cooperation to ensure early identification of potential sources of conflict between scientific opinions between committees, panels and other groups of the two Parties; exchange of information on areas of mutual interest, such as zoonoses, antimicrobial resistance, consumption of veterinary antimicrobial agents, residues in foodstuff of animal origin, maximum residue limits and scientific approach to safe limits for residues, methodologies for risks assessment of substances, genetically modified organisms, indications/health claims for products containing herbal ingredients, and food supplements and additives; exchange of views and coordination as to the handling of scientific questions of common interest and e.g. related to antibiotics in food-producing animals, residues in foodstuffs of animal origin or borderline products (herbal medicinal products and food supplements); mutual invitations to attend meetings convened under their respective auspices or participate in relevant working groups established by either of them in matters in which the other party has an interest or technical competence; 3 OJ L 152, 16.6.2009, P. 11. Memorandum of understanding on working arrangements between EMA and EFSA Page 2/5

implementation of specific joint work projects, e.g. in relation to surveillance and monitoring activities, epidemiological investigations etc., with reference to each party s annual work programme, following approval of the work programmes by the decision-making bodies and taking into account availability of adequate resources; development of scientific guidance on the above topics cooperation in risks communication; exchange of information with a view to greater cooperation in areas such information technology, public procurement, legal matters, and policies and best practice regarding independence and handling conflicts of interest, openness and transparency policies and mechanisms. 3. Mutual consultation The parties undertake to, where possible and appropriate: 3.1. Consult each other regularly and endeavour to keep each other informed on matters of common interest in order to coordinate activities and to avoid contradicting messages; 3.2. Consult each other to ensure the greatest possible degree of coordination with regard to the organisation of meetings and missions of technical experts concerning questions in which both agencies have an interest; 3.3. Have ad hoc consultations on new emerging situations where urgent cooperation would be necessary to avoid potential conflicting scientific opinions. 4. Coordination Each party shall designate one staff member as coordinator for the maintenance of close, direct and continuing contacts with the view to ensuring the application of the provisions of the present working arrangement. These coordinators shall keep and update as necessary, a list of contact persons for the main areas of cooperation. When necessary the coordinators shall convene meetings at the required level between representatives of the two parties. In case of conflicting internal rules of the two agencies, the internal rules of the agency, in which the activity takes place, shall apply. 5. Further implementation Further aspects and details of the cooperation between EMA and EFSA may be developed in the framework of the present Memorandum of Understanding, including the respective roles and responsibilities of involved members of staff and participation as observer to relevant meetings, where needed. 6. Confidentiality of information 6.1. Exchange of information between EMA and EFSA shall only take place for the purpose of, and in accordance with, the provisions of this working arrangement, and may not include data related to identified or identifiable individuals. Exchange of information contained in particular databases at EFSA shall be in accordance with their respective agreements on data sharing. Memorandum of understanding on working arrangements between EMA and EFSA Page 3/5

6.2. The Parties may inform each other, at the moment of the information exchange or before, of the purpose for which the information is intended to be used and of any restriction on its use, deletion or destruction, including possible access restrictions in general or specific terms. Where the need for such restrictions becomes apparent after the supply, the Parties may also indicate to each other such restrictions at a later stage. 6.3. Each Party shall ensure that data or other information received on the basis of this working arrangement shall be subject to its confidentiality and security standards for the processing of information. 6.4. Each Party shall ensure that information received from the other Party receives a level of protection which is equivalent to the level of protection offered by the measures applied to that information by the other Party. In case the implementation of the present point does lead to conflicts with a relevant policy of one of the Parties, the other Party shall be informed in advance. 6.5. In accordance with the principle of proportionality, confidentiality levels shall be attributed at the lowest possible level by each Party and amended accordingly wherever possible. 6.6. The Party supplying the information shall be responsible for the choice of the appropriate confidentiality level for information supplied, and shall ensure that the level is clearly indicated. 6.7. Both Parties may at any time request an amendment of the chosen confidentiality level for information supplied, including the possible removal of such a level. The receiving Party shall be obliged to amend the confidentiality level accordingly. 7. Divergences of Interpretation or Implementation The Parties undertake to cooperate with a view to resolving any divergence that may arise in the interpretation or implementation of the present Memorandum of Understanding in accordance with the provisions of Article 59 of Regulation (EC) No 726/2004 and Article 30 of Regulation (EC) No 178/2002. 8. Amendments The present Memorandum of Understanding may be amended by mutual consent in writing between EMA and EFSA at any time, in accordance with their respective statutory requirements. The present Memorandum of Understanding shall be implemented through technical procedures annexed to this document after mutual written agreement. 9. Termination of the Memorandum of Understanding The present Memorandum of Understanding may be terminated by each of the two Parties giving at least three months written notice or by both Parties via mutual written agreement. Both Parties shall take appropriate measures to ensure minimal damage to ongoing technical collaboration that could results from decision to terminate these working arrangements. Memorandum of understanding on working arrangements between EMA and EFSA Page 4/5

The present memorandum of understanding shall enter into force on the day following the date of signature by both Parties. For the European Medicines Agency: For the European Food Safety Authority: Guido Rasi Executive Director Catherine Geslain-Lanéelle Executive Director Signature: On file Signature: On file Done at: London Done at: London Date: 27 January 2012 Date: 27 January 2012 In duplicate, in English. Memorandum of understanding on working arrangements between EMA and EFSA Page 5/5